Genomics is one of the fastest growing fields of medicine today, and our experience with Covid-19 has only accelerated developments. Hear from Harvard-trained medical geneticist Dr. Marsha Fearing and doctor of pharmacy Anna Dover, director of product management with FDB (First Databank), to get their perspectives on why and how genomics is about to change healthcare in the very near term. They explain how a patient’s unique genetic profile dramatically affects their response to medications and other therapies, and how physicians from all specialties will soon be able use genetic insights at the point of care, without disrupting or slowing their workflows.